Skip to main content
SpringerLink
Log in

Permanent I Interstitial Radiation Therapy in the Treatment of Non-GBM High-Grade Gliomas

  • Published:
Journal of Radiosurgery

Abstract

This study evaluates prognostic factors influencing survival outcomes for 50 patients with permanent125 iodine-125 implants in the primary treatment of non-GBM high-grade gliomas. Stereotactic treatment planning aimed to encompass the contrast-enhancing rim of the tumor visualized by CT, with an initial dose rate of 0.05 Gy/hour with 125I, delivering 100 Gy at 1 year and 103.68 Gy at infinity. Survival was evaluated using the Kaplan–Meier method for unvariate analysis and the Cox regressional method for multivariate analysis. In addition to the implant, 31 patients received external radiation therapy (5000 to 6000 cGy) before the implant; 10 patients were implanted without additional external beam radiation, and 9 patients underwent external radiation therapy before implant placement. With a mean follow-up of 40.76 months (range 3.47–87 months); 1−, 3−, and 5-year survival were 78.5% (± .05%), 58.7% (± .07%), and 56.2% (± .07%) respectively. Since 56.2% of the patients were alive at 5 years, median survival has not been reached yet. Second surgery was performed following the implant in 19 patients. Findings were tumor recurrence in 11 patients (22.5%), radiation necrosis in 7 patients (14.3%), and brain abcess in 1 patient (2%). Age, sex, tumor location, side of brain, tumor volume, Karnofsky, and neurological status were correlated with survival outcome. Favorable prognostic factors were age younger than 45 years, superficial tumor location, and preoperative Karnofsky greater than 70. Surgical treatment of patients with non-GBM high grade gliomas combined with external beam radiation and permanent 125I implants represent a valuable alternative for the treatment of patients with malignant gliomas, allowing patients good quality of life and long survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Abbe R: Radium's contribution to surgery. JAMA 55:97–100, 1910

    Google Scholar 

  2. Black PM: Brain tumors (part I). N Engl J Med 324:1471, 1991

    Google Scholar 

  3. Black PM: Brain tumors (part II). N Engl J Med 324:1555, 1991

    Google Scholar 

  4. Buatti JM, Friedman WA, Bova FJ, Mendenhall WM: Linac radiosurgery for high-grade gliomas: the University of Florida experience. Intern J Radiat Oncol Biol Phys 32:205–210, 1995

    Google Scholar 

  5. Chamberlain MC, Kormanik P: Salvage chemotherapy with paclitaxel for recurrent primary brain tumors. J Clin Oncol 13: 2066–2071, 1995

    Google Scholar 

  6. Choucair AK, Levin VA, Gutin PH, Davis RL, Silver P, Edwards MS, Wilson CB: Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas. J Neurosurg 65:654–658, 1986

    Google Scholar 

  7. Chun M, McKeough P, Wu A, Kasdon D, Heros D, Chang H: Interstitial Iridium-192 implantation for malignant brain tumors. Brit J Radiol 62:158–162, 1989

    Google Scholar 

  8. Danlos H: Quelques considerations sur le traitement des dermatoses par le radium. J Physiother (Paris) 3:98–106, 1905

    Google Scholar 

  9. Fernandez PM, Zamorano L, Yakar D, Gaspar L, Warmelink C: Permanent iodine-125 implants in the up-front treatment of malignant gliomas. Neurosurgery 36:467–473, 1995

    Google Scholar 

  10. Florell RC, MacDonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH, and Cairncross JG: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76:179–183, 1992

    Google Scholar 

  11. Frank F, Fabrizi AP, Frank-Rici R, Sturiale C, and Nuzzo G: Treatment of low malignancy brain neoplasms by means of stereotactic interstitial radiotherapy. Appl Neurophysiol 48:121–126, 1985

    Google Scholar 

  12. Gannett D, Stea B, Lulu B, Adair T, Verdi C, Hamilton A: Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Intern J Radiat Oncol Biol Phys 33:461–468, 1995

    Google Scholar 

  13. Gaspar L, Zamorano L, Shamsa F, Han I, Alekhteyar C, Garcia L, Yakar D: Permanent Iodine-125 implant in malignant glioma. Endocur Hyperther Oncol 11:193–200, 1995

    Google Scholar 

  14. Hall EJ: The biological basis of endocurietherapy: the Henshchke memorial lecture 1984. Hypertherm Oncol 1:141–152, 1985

    Google Scholar 

  15. Imperato JP, Paleologos NA, Vick NA: Effects of treatment on long-term survivors with malignant astrocytomas. Ann Neurol 29:818–882, 1990

    Google Scholar 

  16. Jeremic B, Grujicic D, Antunovic V, Djuric L, Shibamoto Y: Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study. Amer J Clin Oncol 18:449–453, 1995

    Google Scholar 

  17. Kingsley DPE, Kendall BE: CT of the adverse effects of therapeutic radiation of the central nervous system. Amer J Neuroradiol 2:453–460, 1981

    Google Scholar 

  18. Kondziolka D, Lunsford LD, Claaseen D, et al.: Radiobiology of radiosurgery: Part II. The rat C6 glioma model. Neurosurgery 31:280–288, 1992

    Google Scholar 

  19. Kyritsis AP: Chemotherapeutic approaches to the treatment of malignant gliomas. Advan Oncol 8:9–13, 1992

    Google Scholar 

  20. Landy HJ, Schwade JG, Houdek PV, Markoe AM, Feun L: Longterm follow-up of gliomas treated with fractionated stereotactic irradiation. Acta Neurochir (Suppl) 62:67–71, 1994

    Google Scholar 

  21. Leibel SA, Gutin PH, Wara WM, Silver PS, Larson DA, Edwards MS, Lamb SA, Ham B, Weaver KA, Barnett C: Survival and quality of life after interstitial implantation of removable highactivity Iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Intern J Radiat Oncol Biol Phys 17: 1129–1139, 1989

    Google Scholar 

  22. Leibel SA, Sheline GE: Radiation therapy for neoplasms of the brain. J Neurosurg 66:1–22, 1987

    Google Scholar 

  23. Leibel SA: Interstitial irradiation for the treatment of primary and metastatic brain tumors. Principles Practice Oncol 3(7), 1989

  24. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of post radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Intern J Radiat Oncol Biol Phys 18:321–324, 1990

    Google Scholar 

  25. Levin VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, and Wilson CB. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of malignant gliomas. Int J Radiat Oncol Biol Phys 30:75–83, 1995

    Google Scholar 

  26. Lukas GL, Luxton G, Cohen D, Petrovich Z, Langholz B, Apuzzo M, Sapozink MD: Treatment results of stereotactic interstitial brachytherapy for primary and metastatic brain tumors. Intern J Radiat Oncol Biol Phys 21:715–721, 1991

    Google Scholar 

  27. Malkin MG: Interstitial irradiation of malignant gliomas. Rev Neurol (Paris) 148:448–453, 1992

    Google Scholar 

  28. Marin LA, Smith CE, Langston MY, Quashie D, Dillehay LE: Response of glioblastoma cell lines to low dose rate irradiation. Intern J Radiat Oncol Biol Phys 21:397–402, 1991

    Google Scholar 

  29. Martins AN, Johnston JS, Henry JM, Stoffel TJ, Di Chiro G: Delayed radiation necrosis of the brain. J Neurosurg 47:336–345, 1977

    Google Scholar 

  30. Masciopinto JE, Levin AB, Mehta MP, Rhode BS: Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg 82:530–535, 1995

    Google Scholar 

  31. Mc Laughlin P, Mancini WR, Stetson PL, Greenberg HS, Nguyen N, Seabury H, Heidorn DB, Lawrence TS: Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. Intern Radiat Oncol Biol Phys 26:637–642, 1993

    Google Scholar 

  32. Miller PJ, Hassanein RS, Shankar Giri PG, Kimler BF, O'Boynick P, Evans RG: Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factors. Intern J Radiat Oncol Biol Phys 19:275–280, 1990

    Google Scholar 

  33. Mundinger F: Long term results of stereotactic interstitial curietherapy. Acta Neurochir (Suppl) 33:367–371, 1984

    Google Scholar 

  34. Mundinger F: Die interstitielle radio-isotopen-bestrahlung von hirntumoren mit vergleichenden langzeiterggebnissen zur rontgentiefentheraphie. Acta Neurochir (Wien) 11:89–109, 1964

    Google Scholar 

  35. Ostertag CB: Biopsy and interstitial radiation therapy of cerebral gliomas. Ital J Neurol Sci (Suppl) 2:121–128, 1983

    Google Scholar 

  36. Rostomily RC, Spence AM, Duong D, McCormick K, Bland M, Berger MS: Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery. Neurosurgery 35:378–388, 1994

    Google Scholar 

  37. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, Lamb SA, Ham B, Gutin PA: High activity Iodine-125 interstitial implant for gliomas. Intern J Radiat Oncol Biol Phys 24:583–591, 1992

    Google Scholar 

  38. Seither RB, Jose B, Paris KJ, Lindberg RD, Spanos WJ: Results of irradiation in patients with high-grade gliomas evaluated by magnetic resonance imaging. Amer J Clin Oncol 18:297–299, 1995

    Google Scholar 

  39. Sheline GE: Radiotherapy for high-grade gliomas. Intern J Radiat Oncol Biol Phys 18:793–803, 1990

    Google Scholar 

  40. Sneed PK, Gutin PH, Prados MD, Phillips TL, Weaver KA, Wara WM, Larson DA: Brachytherapy of brain tumors. Stereotact Func Neurosurg 59:157–165, 1992

    Google Scholar 

  41. Stea BS, Kittelson J, Cassady JR, Hamilton A, Guthkelch N, Lulu B, Obbens E, Rossman K, Shapiro W, Shetter A, Cetas T: Treatment of malignant gliomas with interstitial irradiation and hyperthermia. Intern J Radiat Oncol Biol Phys 24:657–667, 1992

    Google Scholar 

  42. Talairach J, Ruggiero G, Aboulker J, David M: A new method of treatment of inoperable brain tumors by stereotaxic implantation of radioactive gold. A preliminary report. Brit J Radiol 28:62–74, 1955

    Google Scholar 

  43. Walker MD, Alexander E, Jr., Hunt WE, McCarthy CS, Mahaley MS, Jr., Mealey J, Jr., Norrel HA, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Jr., Wilson CB, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343, 1978

    Google Scholar 

  44. Walker MD, Green SB, Byar DP, Alexander E, Jr., Batzdorf U, Brooks WH, Hunt WE, McCarthy CS, Mahaley MS, Jr., Mealey J, Jr., Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, J Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosureas for malignant gliomas after surgery. N Engl J Med 303:1323–1329, 1980

    Google Scholar 

  45. Wallner KE, Galicick JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Intern J Radiat Oncol Biol Phys 16:1405–1409, 1989

    Google Scholar 

  46. Zamorano L, Gaspar L: Low-dose-rate brachytherapy in the treatment of malignant gliomas. In P Gildemberg (ed) Stereotactic and Functional Neurosurgery, New York, McGraw-Hill, 1997, pp. 607–616

    Google Scholar 

  47. Zamorano L, Yakar D, Dujovny M, Sheenan M, Kim J: Permanent Iodine-125 implant and external beam radiation therapy for the treatment of malignant brain tumors. Stereotact Funct Neurosurg 59:183–192, 1992

    Google Scholar 

  48. Zamorano L, Yakar D, Dujovny M, Sheenan M, Kim J: Permanent Iodine-125 implant and external beam radiation therapy for the treatment of malignant brain tumors. Stereotact Funct Neurosurg 58:95–141, 1991

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurological Surgery, Wayne State University, 4160 John R Suite 930, Detroit, Michigan, 48201

    Federico C. Vinas & Amgad Matter

  2. Department of Neurological Surgery, Wayne State University, 4160 John R Suite 930, Detroit, Michigan, 48201

    Lucia Zamorano

  3. Radiation Oncology, Wayne State University, Detroit, Michigan, 48201

    Laurie E. Gaspar & Falah Shamsa

Authors
  1. Federico C. Vinas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucia Zamorano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laurie E. Gaspar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amgad Matter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Falah Shamsa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vinas, F.C., Zamorano, L., Gaspar, L.E. et al. Permanent I Interstitial Radiation Therapy in the Treatment of Non-GBM High-Grade Gliomas. Journal of Radiosurgery 3, 91–98 (2000). https://doi.org/10.1023/A:1009537718648

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009537718648

Search

Navigation